<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03638973</url>
  </required_header>
  <id_info>
    <org_study_id>2018-01364</org_study_id>
    <nct_id>NCT03638973</nct_id>
  </id_info>
  <brief_title>Comparison of Sample Biopsy Using Scalpel or Er:YAG Laser</brief_title>
  <official_title>Randomized Prospective Study for the Comparison of Sample Biopsy Using Scalpel or Er:YAG Laser</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      For certain changes in the oral mucosa a histopathological examination of the affected tissue
      is indicated to confirm the diagnosis. The gold standard is the biopsy by scalpel. The aim of
      this study is to compare the alternative method of tissue sampling using the erbium doped
      yttrium aluminium garnet (Er:YAG) laser with the gold Standard.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Various parameters are compared, such as the pain intensity during and after the biopsy, the
      evaluation of the tissue removed by the histopathologist, the occurrence of bleeding during
      and after the removal and the time required for both therapies.

      Patients who agree to participate in the study will be randomized (randomly) to either
      therapy.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2018</start_date>
  <completion_date type="Anticipated">November 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>histological assessability</measure>
    <time_frame>13 month</time_frame>
    <description>The primary endpoint is the histological assessability of the samples. This is evaluated by the histologist and divided into degrees 0-3. The
Subdivision of the artifacts takes place according to the following degrees:
0: none, 1: slight artifacts, not affecting the evaluation of the sample, 2: moderate artifacts, slight deterioration in the evaluability of the sample, 3: severe artifacts, severely impaired</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>13 month</time_frame>
    <description>The pain is measured by the visual analogue scale (VAS) 0-10, 0 = no pain, 10 = worst possible pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative bleeding</measure>
    <time_frame>13 month</time_frame>
    <description>The bleeding is determined with yes or no.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time for removal</measure>
    <time_frame>13 month</time_frame>
    <description>The time to remove is measured in seconds</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Laser Burn</condition>
  <condition>Gingival Disease</condition>
  <condition>Biopsy Wound</condition>
  <arm_group>
    <arm_group_label>Biopsy with Er: YAG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Removal of specimen biopsies in patients with leukoplakic or lichenoid mucosal lesions using Er: YAG laser under previous local anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biopsy with Scalpel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Biopsies taken with Er: YAG are compared with biopsies taken with a scalpel in patients with lichenoid or leukoplakic changes of the oral mucosa.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biopsy</intervention_name>
    <description>Removal of specimen biopsies in patients with leukoplakic or lichenoid mucosal lesions using Er: YAG laser or scalpel under previous local anesthesia.</description>
    <arm_group_label>Biopsy with Er: YAG</arm_group_label>
    <arm_group_label>Biopsy with Scalpel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication for biopsy of the oral mucosa

          -  male and female adult patients

          -  Written consent of the participating persons after clarification

        Exclusion Criteria:

          -  pregnancy

          -  Taking blood thinners

          -  Known infectious diseases

          -  Untreated diabetes mellitus

          -  Taking immunosuppressants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Rücker, Prof.Dr.Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sponsor GmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barbara Giacomelli-Hiestand, Dr.</last_name>
    <phone>+41446343290</phone>
    <email>barbara.giacomelli-hiestand@zz.uzh.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinic for Oral Surgery, Center of dental medicine, University of Zurich</name>
      <address>
        <city>Zürich</city>
        <zip>8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <results_reference>
    <citation>Suter VGA, Altermatt HJ, Bornstein MM. A randomized controlled clinical and histopathological trial comparing excisional biopsies of oral fibrous hyperplasias using CO(2) and Er:YAG laser. Lasers Med Sci. 2017 Apr;32(3):573-581. doi: 10.1007/s10103-017-2151-8. Epub 2017 Jan 24.</citation>
    <PMID>28120248</PMID>
  </results_reference>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>August 13, 2018</study_first_submitted>
  <study_first_submitted_qc>August 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2018</study_first_posted>
  <last_update_submitted>October 11, 2018</last_update_submitted>
  <last_update_submitted_qc>October 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gingival Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

